Ignite Creation Date:
2025-12-24 @ 4:52 PM
Ignite Modification Date:
2026-05-09 @ 3:08 PM
Study NCT ID:
NCT05485350
Status:
UNKNOWN
Last Update Posted:
2022-08-03
First Post:
2022-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Organization: